{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:01:24Z","timestamp":1790060484474,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":32,"publisher":"Springer US","isbn-type":[{"value":"9781071655306","type":"print"},{"value":"9781071655313","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5531-3_21","type":"book-chapter","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:33:54Z","timestamp":1790055234000},"page":"295-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methods for Identifying Type III Secretion System Effectors in Chlamydia trachomatis"],"prefix":"10.1007","author":[{"given":"Robert","family":"Faris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"21_CR1","doi-asserted-by":"publisher","first-page":"ftaa078","DOI":"10.1093\/femspd\/ftaa078","volume":"79","author":"SE Andersen","year":"2021","unstructured":"Andersen SE, Bulman LM, Steiert B et al (2021) Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins. Pathog Dis 79:ftaa078. https:\/\/doi.org\/10.1093\/femspd\/ftaa078","journal-title":"Pathog Dis"},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrmicro.2016.30","volume":"14","author":"C Elwell","year":"2016","unstructured":"Elwell C, Mirrashidi K, Engel J (2016) Chlamydia cell biology and pathogenesis. Nat Rev Microbiol 14:385\u2013400. https:\/\/doi.org\/10.1038\/nrmicro.2016.30","journal-title":"Nat Rev Microbiol"},{"key":"21_CR3","doi-asserted-by":"publisher","first-page":"e0004859","DOI":"10.1371\/journal.pntd.0004859","volume":"10","author":"AM Ramadhani","year":"2016","unstructured":"Ramadhani AM, Derrick T, Holland MJ, Burton MJ (2016) Blinding trachoma: systematic review of rates and risk factors for progressive disease. PLoS Neglected Trop Dis 10:e0004859. https:\/\/doi.org\/10.1371\/journal.pntd.0004859","journal-title":"PLoS Neglected Trop Dis"},{"key":"21_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/14760584.2021.1899817","volume":"20","author":"LM Maza","year":"2021","unstructured":"Maza LM, de la, Darville TL, Pal S (2021) Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?. Expert Rev Vaccines 20:421\u2013435. https:\/\/doi.org\/10.1080\/14760584.2021.1899817","journal-title":"Expert Rev Vaccines"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/s1470-2045(18)30421-2","volume":"19","author":"M Das","year":"2018","unstructured":"Das M (2018) Chlamydia infection and ovarian cancer risk. Lancet Oncol 19:e338. https:\/\/doi.org\/10.1016\/s1470-2045(18)30421-2","journal-title":"Lancet Oncol"},{"key":"21_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<35::AID-IJC6>3.0.CO;2-A","volume":"85","author":"P Koskela","year":"2000","unstructured":"Koskela P, Anttila T, Bj\u00f8rge T et al (2000) Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 85:35\u201339","journal-title":"Int J Cancer"},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00404-013-3122-3","volume":"289","author":"J Silva","year":"2014","unstructured":"Silva J, Cerqueira F, Medeiros R (2014) Chlamydia trachomatis infection: implications for HPV status and cervical cancer. Arch Gynecol Obstet 289:715\u2013723. https:\/\/doi.org\/10.1007\/s00404-013-3122-3","journal-title":"Arch Gynecol Obstet"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1462-5822.2000.00029.x","volume":"2","author":"Bannantine","year":"2000","unstructured":"Bannantine, Griffiths, Viratyosin et al (2000) A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol 2:35\u201347. https:\/\/doi.org\/10.1046\/j.1462-5822.2000.00029.x","journal-title":"Cell Microbiol"},{"key":"21_CR9","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1128\/iai.01075-15","volume":"83","author":"MM Weber","year":"2015","unstructured":"Weber MM, Bauler LD, Lam J, Hackstadt T (2015) Expression and localization of predicted inclusion membrane proteins in Chlamydia trachomatis. Infect Immun 83:4710\u20134718. https:\/\/doi.org\/10.1128\/iai.01075-15","journal-title":"Infect Immun"},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1046\/j.1365-2958.1999.01523.x","volume":"33","author":"MA Scidmore-Carlson","year":"1999","unstructured":"Scidmore-Carlson MA, Shaw EI, Dooley CA et al (1999) Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol Microbiol 33:753\u2013765. https:\/\/doi.org\/10.1046\/j.1365-2958.1999.01523.x","journal-title":"Mol Microbiol"},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1128\/iai.00010-08","volume":"76","author":"Z Li","year":"2008","unstructured":"Li Z, Chen C, Chen D et al (2008) Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun 76:2746\u20132757. https:\/\/doi.org\/10.1128\/iai.00010-08","journal-title":"Infect Immun"},{"key":"21_CR12","doi-asserted-by":"publisher","unstructured":"Faris R, Koch R, McCaslin P et al (2025) The Chlamydia trachomatis secreted effector protein CT181 binds to Mcl-1 to prolong neutrophil survival. bioRxiv 2025.03.16.643443. https:\/\/doi.org\/10.1101\/2025.03.16.643443","DOI":"10.1101\/2025.03.16.643443"},{"key":"21_CR13","doi-asserted-by":"publisher","unstructured":"McCaslin PN, Andersen SE, Icardi CM et al (2023) Identification and preliminary characterization of novel type III secreted effector proteins in Chlamydia trachomatis. Infect Immun e0049122. https:\/\/doi.org\/10.1128\/iai.00491-22","DOI":"10.1128\/iai.00491-22"},{"key":"21_CR14","doi-asserted-by":"publisher","unstructured":"McCaslin PN, Andersen SE, Smith P et al (2025) Validation and subcellular localization of previously predicted type III secreted effector proteins in Chlamydia trachomatis. Microbiol Spectr e0161625. https:\/\/doi.org\/10.1128\/spectrum.01616-25","DOI":"10.1128\/spectrum.01616-25"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/iai.02763-14","volume":"83","author":"CL Larson","year":"2014","unstructured":"Larson CL, Beare PA, Voth DE et al (2014) Coxiella burnetii effector proteins that localize to the parasitophorous vacuole membrane promote intracellular replication. Infect Immun 83:661\u2013670. https:\/\/doi.org\/10.1128\/iai.02763-14","journal-title":"Infect Immun"},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.1128\/iai.73.10.6260-6271.2005","volume":"73","author":"K Geddes","year":"2005","unstructured":"Geddes K, Worley M, Niemann G, Heffron F (2005) Identification of new secreted effectors in Salmonella enterica Serovar Typhimurium. Infect Immun 73:6260\u20136271. https:\/\/doi.org\/10.1128\/iai.73.10.6260-6271.2005","journal-title":"Infect Immun"},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"11998","DOI":"10.1073\/pnas.92.26.11998","volume":"92","author":"MP Sory","year":"1995","unstructured":"Sory MP, Boland A, Lambermont I, Cornelis GR (1995) Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach. Proc Natl Acad Sci 92:11998\u201312002. https:\/\/doi.org\/10.1073\/pnas.92.26.11998","journal-title":"Proc Natl Acad Sci"},{"key":"21_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/s0966-842x(99)01468-7","volume":"7","author":"D Ladant","year":"1999","unstructured":"Ladant D, Ullmann A (1999) Bordetella pertussis adenylate cyclase: a toxin with multiple talents. Trends Microbiol 7:172\u2013176. https:\/\/doi.org\/10.1016\/s0966-842x(99)01468-7","journal-title":"Trends Microbiol"},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/j.1365-2958.2008.06487.x","volume":"70","author":"MFD Jong","year":"2008","unstructured":"Jong MFD, Sun Y, Hartigh ABD et al (2008) Identification of VceA and VceC, two members of the VjbR regulon that are translocated into macrophages by the Brucella type IV secretion system. Mol Microbiol 70:1378\u20131396. https:\/\/doi.org\/10.1111\/j.1365-2958.2008.06487.x","journal-title":"Mol Microbiol"},{"key":"21_CR20","doi-asserted-by":"publisher","unstructured":"Newton P, Latomanski EA, Newton HJ (2016) Applying fluorescence resonance energy transfer (FRET) to examine effector translocation efficiency by Coxiella burnetiid during siRNA silencing. J Vis Exp 113:e54210. https:\/\/doi.org\/10.3791\/54210","DOI":"10.3791\/54210"},{"key":"21_CR21","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1128\/jb.00071-13","volume":"195","author":"MM Weber","year":"2013","unstructured":"Weber MM, Chen C, Rowin K et al (2013) Identification of Coxiella burnetii Type IV secretion substrates required for intracellular replication and Coxiella-containing vacuole formation. J Bacteriol 195:3914\u20133924. https:\/\/doi.org\/10.1128\/jb.00071-13","journal-title":"J Bacteriol"},{"key":"21_CR22","doi-asserted-by":"publisher","first-page":"21755","DOI":"10.1073\/pnas.1010485107","volume":"107","author":"C Chen","year":"2010","unstructured":"Chen C, Banga S, Mertens K et al (2010) Large-scale identification and translocation of type IV secretion substrates by Coxiella burnetii. Proc National Acad Sci 107:21755\u201321760. https:\/\/doi.org\/10.1073\/pnas.1010485107","journal-title":"Proc National Acad Sci"},{"key":"21_CR23","doi-asserted-by":"publisher","first-page":"e0135295","DOI":"10.1371\/journal.pone.0135295","volume":"10","author":"KE Mueller","year":"2015","unstructured":"Mueller KE, Fields KA (2015) Application of \u03b2-lactamase reporter fusions as an indicator of effector protein secretion during infections with the obligate intracellular pathogen Chlamydia trachomatis. PLOS One 10:e0135295. https:\/\/doi.org\/10.1371\/journal.pone.0135295","journal-title":"PLOS One"},{"key":"21_CR24","doi-asserted-by":"publisher","first-page":"e1000117","DOI":"10.1371\/journal.ppat.1000117","volume":"4","author":"KS Felipe","year":"2008","unstructured":"Felipe KS, de, Glover RT, Charpentier X et al (2008) Legionella eukaryotic-like type IV substrates interfere with organelle trafficking. PLoS Pathog 4:e1000117. https:\/\/doi.org\/10.1371\/journal.ppat.1000117","journal-title":"PLoS Pathog"},{"key":"21_CR25","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1128\/jb.186.16.5486-5495.2004","volume":"186","author":"X Charpentier","year":"2004","unstructured":"Charpentier X, Oswald E (2004) Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli Effector Cif, using TEM-1 \u03b2-lactamase as a new fluorescence-based reporter. J Bacteriol 186:5486\u20135495. https:\/\/doi.org\/10.1128\/jb.186.16.5486-5495.2004","journal-title":"J Bacteriol"},{"key":"21_CR26","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1128\/iai.73.12.7817-7826.2005","volume":"73","author":"M Raffatellu","year":"2005","unstructured":"Raffatellu M, Sun Y-H, Wilson RP et al (2005) Host restriction of Salmonella enterica Serotype Typhi is not caused by functional alteration of SipA, SopB, or SopD. Infect Immun 73:7817\u20137826. https:\/\/doi.org\/10.1128\/iai.73.12.7817-7826.2005","journal-title":"Infect Immun"},{"key":"21_CR27","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1128\/iai.00690-06","volume":"74","author":"JT Garcia","year":"2006","unstructured":"Garcia JT, Ferracci F, Jackson MW et al (2006) Measurement of effector protein injection by type III and type IV secretion systems by using a 13-residue phosphorylatable glycogen synthase kinase tag. Infect Immun 74:5645\u20135657. https:\/\/doi.org\/10.1128\/iai.00690-06","journal-title":"Infect Immun"},{"key":"21_CR28","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1128\/jb.01290-13","volume":"196","author":"LD Bauler","year":"2014","unstructured":"Bauler LD, Hackstadt T (2014) Expression and targeting of secreted proteins from Chlamydia trachomatis. J Bacteriol 196:1325\u20131334. https:\/\/doi.org\/10.1128\/jb.01290-13","journal-title":"J Bacteriol"},{"key":"21_CR29","doi-asserted-by":"publisher","unstructured":"Lehman SS, Noriea NF, Aistleitner K, et al (2018) The Rickettsial Ankyrin Repeat Protein 2 is a type IV secreted effector that associates with the endoplasmic reticulum. mBio 9:10.1128\/mbio.00975-18. https:\/\/doi.org\/10.1128\/mbio.00975-18","DOI":"10.1128\/mbio.00975-18"},{"key":"21_CR30","doi-asserted-by":"publisher","unstructured":"Yanatori I, Miura K, Chen Y-S et al (2021) Application of a Chlamydia trachomatis expression system to identify Chlamydia pneumoniae proteins translocated into host cells. J Bacteriol 203. https:\/\/doi.org\/10.1128\/jb.00511-20","DOI":"10.1128\/jb.00511-20"},{"key":"21_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-1-4939-9694-0_11","volume":"2042","author":"K Wolf","year":"2019","unstructured":"Wolf K, Rahnama M, Fields KA (2019) Chlamydia trachomatis, methods and protocols. Methods Mol Biol 2042:151\u2013164. https:\/\/doi.org\/10.1007\/978-1-4939-9694-0_11","journal-title":"Methods Mol Biol"},{"key":"21_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4939-9694-0_12","volume":"2042","author":"MM Weber","year":"2019","unstructured":"Weber MM, Faris R (2019) Mutagenesis of Chlamydia trachomatis using TargeTron. Methods Mol Biol 2042:165\u2013184. https:\/\/doi.org\/10.1007\/978-1-4939-9694-0_12","journal-title":"Methods Mol Biol"}],"container-title":["Methods in Molecular Biology","Chlamydia trachomatis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5531-3_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:02:47Z","timestamp":1790056967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5531-3_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"ISBN":["9781071655306","9781071655313"],"references-count":32,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5531-3_21","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"23 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this chapter.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}